glp-1 for obesity thibodaux GLP-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon GLP-1 Therapy Part 1: Setting

GLP-1 medicines decrease the rates of complications associated with obesity and T2D

Tell your medical professional that youre an athlete and subject to drug testing

In comparison, studies show that Mounjaro users lost 22.5% of their body weight on average after 72 weeks, and Wegovy users taking a 7.2mg dose lost up to 20.7% of their body weight after 72 weeks

If glucose readings are elevated, checking for ketones may be warranted, particularly if accompanied by symptoms such as nausea, vomiting, abdominal pain, rapid breathing, or confusion, which could indicate diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) requiring urgent medical attention